Home › NDC Lookup › RxCUI directory › RxCUI 2698206

Zanidatamab-hrii 300 MG Injection — RxCUI 2698206

Name: Zanidatamab-hrii 300 MG Injection (RxCUI 2698206)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2698206 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2698206

Official nameZanidatamab-hrii 300 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)12 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Zanidatamab-hrii 300 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Zanidatamab-hrii 300 MG Injection RxCUI 2698206 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Zanidatamab 2698198 IN
- Zanidatamab-hrii 2698200 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Ziihera 2698207 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Zanidatamab Injection 2698203 SCDF
- Zanidatamab-hrii Injection 2698205 SCDFP
- Zanidatamab Injectable Product 2698202 SCDG
- Zanidatamab-hrii Injectable Product 2698204 SCDGP
- Zanidatamab Injection [Ziihera] 2698210 SBDF
- Zanidatamab-hrii Injection [Ziihera] 2698211 SBDFP
- Ziihera Injectable Product 2698209 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Zanidatamab-hrii 300 MG 2698201 SCDC
- Zanidatamab-hrii 300 MG Injection [Ziihera] 2698212 SBD
- Zanidatamab-hrii 300 MG [Ziihera] 2698208 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Zanidatamab-hrii 300 MG SCDC · 2698201
Zanidatamab Injection SCDF · 2698203
Zanidatamab-hrii Injection SCDFP · 2698205
Zanidatamab Injectable Product SCDG · 2698202
Zanidatamab-hrii Injectable Product SCDGP · 2698204

Brand-Name Concepts

Zanidatamab-hrii 300 MG Injection [Ziihera] SBD · 2698212
Zanidatamab-hrii 300 MG [Ziihera] SBDC · 2698208
Zanidatamab Injection [Ziihera] SBDF · 2698210
Zanidatamab-hrii Injection [Ziihera] SBDFP · 2698211
Ziihera Injectable Product SBDG · 2698209
Ziihera BN · 2698207

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2698206 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
68727-0950-02	2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1...	ZIIHERA	Jazz Pharmaceuticals, Inc.	2024-11-20

Observed labelers: Jazz Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9276	Inj zanidatamab-hrii, 2 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.